RSS | Archive | Random

About

Poly Cystic Ovarian Syndrome is an incurable disease affecting approximately 10% of the female population.
Golden Shoes is an organization established to bring awareness to the world about PCOS and is also a resource for women and their support networks in dealing with this frustrating disease.

Links


Sign up for the official Golden Shoes eNewsletter!





Golden Shoes Website
Golden Shoes Twitter
Cole's Personal Blog
Golden Shoes'Social Network

Who's Behind Golden Shoes?

Cole Imperi is the Director and Founder of Golden Shoes. She was diagnosed with PCOS in April of 2008. Kara Evans is the President of Golden Shoes.

The whole purpose of Golden Shoes is to introduce you to someone who has PCOS. Someone that's real and accessible. When Cole was first diagnosed, all she wanted was someone to talk to who had it. Kara did too. It was hard enough for us to shuffle through the often contradictory information found on the internet, so our goal is to give you access to good information, a community of supportive women, and something positive.
If you want to talk, get in touch!

Following

4 November 09
Comments (View)
22 May 09

Study | Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.

Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.

From: HERE

Thomson R, Buckley J, Moran L, Noakes M, Clifton P, Norman R, Brinkworth G.

Australian Technology Network Centre for Metabolic Fitness & Nutritional Physiology Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia.

Objective
To assess maximal aerobic capacity () and muscle strength in overweight and obese women with polycystic ovary syndrome (PCOS) and determine their relationship with metabolic and hormonal factors. Design Cross-sectional study. Setting Clinical Research Unit. Population Overweight and obese women with PCOS (n = 10) and age-and weight-matched healthy controls (n = 16). Methods was measured during an incremental treadmill test and maximal isometric (ImS) and isokinetic knee extensor strength (IkS) (120 degrees /second) were assessed by isokinetic dynamometry. Main outcome measures , ImS, IkS, waist circumference, blood lipids, glucose, insulin, insulin resistance (homeostatic model assessment [HOMA2]), C-reactive protein (CRP), hormonal profile.

Results
PCOS women had higher levels of testosterone and free testosterone (P </= 0.05), but there were no significant differences in any cardiovascular disease (CVD) risk markers between the groups. was similar in women with PCOS and healthy controls (PCOS 26.0 +/- 4.1 ml/kg/minute, controls 25.7 +/- 3.8 ml/kg/minute; P = 0.90), as was ImS (PCOS 1.50 +/- 0.54 Nm/kg, controls 1.50 +/- 0.47 Nm/kg; P = 0.96) and IkS (PCOS 1.04 +/- 0.32 Nm/kg, controls 1.16 +/- 0.23 Nm/kg; P = 0.32). was inversely related to waist circumference, insulin, HOMA2 and CRP. Waist circumference was inversely associated with ImS and IkS. No significant associations between exercise parameters and hormonal variables were identified.

Conclusions
Compared to age- and weight-matched healthy overweight and obese women with similar insulin resistance and CVD risk profiles, women with PCOS had similar aerobic capacity and muscle strength. This suggests PCOS, at least in the absence of an adverse metabolic profile is unlikely to limit physical function. Larger studies examining the effects of PCOS on exercise tolerance in a diverse range of PCOS phenotypes is required.

PMID: 19438498 [PubMed - as supplied by publisher

Comments (View)
Themed by Hunson. Originally by Josh